Log inSign up
AAOIFI No. 21 screening

Is RIGL halal?

Rigel Pharmaceuticals, Inc.

Halal

Rigel Pharmaceuticals, Inc. passed every check under AAOIFI Shariah standard No. 21: no prohibited business activity, and all three financial ratios are within limits.

Checked: 10 October 2026

Exchange

NASDAQ

Price

47.14

Day

-3.42%

Market cap

$908.1M

Industry

Biotechnology

Sector

Healthcare

What the company does

Rigel Pharmaceuticals sells hematology and oncology medicines: Tavalisse (immune thrombocytopenia), Rezlidhia (acute myeloid leukemia) and Gavreto. Its money comes from prescription-drug sales.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $39.24M ÷ 36-month average market cap $402.06M = 9.8%

    9.8%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $95.33M ÷ 36-month average market cap $402.06M = 23.7%

    23.7%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $3.68M ÷ annual revenue $294.28M (2025) = 1.3%

    1.3%

    Pass

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $908.08M.

For information (AAOIFI 3/1 note): cash + receivables are 29.1% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500
Among halal stocks
0.00% · #908 of 1454

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyRIGL's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →